These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22286742)

  • 1. [Ocular and cardiac toxicity by chloroquine].
    Gentille Lorente DI
    Rev Med Chil; 2011 Oct; 139(10):1384-6. PubMed ID: 22286742
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiomyopathy related to antimalarial therapy with illustrative case report.
    Costedoat-Chalumeau N; Hulot JS; Amoura Z; Delcourt A; Maisonobe T; Dorent R; Bonnet N; Sablé R; Lechat P; Wechsler B; Piette JC
    Cardiology; 2007; 107(2):73-80. PubMed ID: 16804295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eye toxicity of antimalarial agents].
    Graña Gil J; Cabana Vázquez M; Vázquez González A; Sánchez Meizoso MO
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac toxicity secondary to long term treatment with chloroquine.
    Cervera A; Espinosa G; Font J; Ingelmo M
    Ann Rheum Dis; 2001 Mar; 60(3):301. PubMed ID: 11245140
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monitoring and prevention of iatrogenic ocular effect in general therapy].
    Le Rebeller MJ; Lanneluc C; Lotte C
    Annee Ther Clin Ophtalmol; 1981; 32():269-92. PubMed ID: 7348132
    [No Abstract]   [Full Text] [Related]  

  • 6. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1967; ():Suppl 92:1-71. PubMed ID: 4866642
    [No Abstract]   [Full Text] [Related]  

  • 7. Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.
    Leecharoen S; Wangkaew S; Louthrenoo W
    J Med Assoc Thai; 2007 Jan; 90(1):52-8. PubMed ID: 17621733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete heart block as a rare complication of treatment with chloroquine.
    Reuss-Borst M; Berner B; Wulf G; Müller GA
    J Rheumatol; 1999 Jun; 26(6):1394-5. PubMed ID: 10381062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third-degree atrioventricular block in a patient under chloroquine therapy.
    Guedira N; Hajjaj-Hassouni N; Srairi JE; el Hassani S; Fellat R; Benomar M
    Rev Rhum Engl Ed; 1998 Jan; 65(1):58-62. PubMed ID: 9523387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine.
    Stas P; Faes D; Noyens P
    Int J Cardiol; 2008 Jul; 127(2):e80-2. PubMed ID: 17590456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.
    Costedoat-Chalumeau N; Hulot JS; Amoura Z; Leroux G; Lechat P; Funck-Brentano C; Piette JC
    Rheumatology (Oxford); 2007 May; 46(5):808-10. PubMed ID: 17202178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular damage in chloroquine therapy.
    Nylander U
    Acta Ophthalmol (Copenh); 1966; 44(3):335-48. PubMed ID: 5953229
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complete heart block following chronic chloroquine treatment].
    Duvic C; Pats B; Rouvier B
    Rev Med Interne; 2000 May; 21(5):462-3. PubMed ID: 10874768
    [No Abstract]   [Full Text] [Related]  

  • 15. Chloroquine-induced subacute paranoid-like disorder as a complication of dermatological treatment.
    Bogaczewicz A; Sobow T; Bogaczewicz J; Bienkowski P; Kowalski J; Wozniacka A
    Int J Dermatol; 2016 Dec; 55(12):1378-1380. PubMed ID: 26967266
    [No Abstract]   [Full Text] [Related]  

  • 16. Chloroquine cardiomyopathy: beyond ocular adverse effects.
    Lopez-Ruiz N; Uribe CE
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25225192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.
    Wozniacka A; Cygankiewicz I; Chudzik M; Sysa-Jedrzejowska A; Wranicz JK
    Lupus; 2006; 15(8):521-5. PubMed ID: 16942005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.
    Lesiak A; Narbutt J; Sysa-Jedrzejowska A; Lukamowicz J; McCauliffe DP; Wózniacka A
    Lupus; 2010 May; 19(6):683-8. PubMed ID: 20064914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarials in the management of discoid and systemic lupus erythematosus.
    Dubois EL
    Semin Arthritis Rheum; 1978 Aug; 8(1):33-51. PubMed ID: 358397
    [No Abstract]   [Full Text] [Related]  

  • 20. The efficacy of antimalarials in systemic lupus erythematosus.
    Rudnicki RD; Gresham GE; Rothfield NF
    J Rheumatol; 1975 Sep; 2(3):323-30. PubMed ID: 1102684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.